In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they plan to reclassify marijuana for a Program III drug. This rescheduling will recognize that cannabis has legitimate clinical applications and should help open the door to investigation on other prospective treatment method works by using.The thoughts expressed will be the creator